Regional Expansion DNASTAR has leveraged a distribution partnership to reach South India, signaling a scalable channel strategy. There is an opportunity to repeat this approach in other growth regions with localized sales, regional support, and co-marketing to drive Lasergene and NovaFold AI adoption among mid-sized labs and universities.

AI Upsell With NovaFold AI and ongoing Lasergene updates, there is a clear cross-sell opportunity to existing Lasergene customers for AI-enabled protein structure prediction and advanced genomics analysis. Offer bundled licenses, easy add-ons, and pilot projects to demonstrate ROI.

Genomics Partnerships Past collaboration with Genomenon on variant analysis shows interest in clinical genomics workflows. Position DNASTAR as an integrated solution for variant interpretation, leveraging Lasergene, NovaFold AI, and Genomenon data for biotech and CRO customers.

SMB Fit DNASTAR's package model with complete suites or individual modules suits small to mid-size life science labs seeking scalable, cost-aware software. Emphasize modular pricing, flexible licensing, and strong local support to win new accounts.

AI Genomics Trend DNASTAR's focus on AI-driven structure prediction and genomics aligns with market demand for reproducible computational biology tools. Target pharma and biotech labs exploring AI workflows, offering pilots and ecosystem partnerships to accelerate tool adoption.